Nevadistinel

N/A

Report date: 2023/11/30 17:43:48
NME

Base Information

Drug NameNevadistinel
Drug Alias NameNYX-458NYX-3054
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor modulators
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsCognitive DysfunctionDementiaParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAptinyx Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptinyx Inc
Inactive CompaniesN/A
Active IndicationsCognitive DysfunctionDementiaParkinson Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG